DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Triazolam (Triazolam) - Summary

 

-- advertisement --

TRIAZOLAM SUMMARY

TRIAZOLAM Tablets USP
0.125 mg and 0.25 mg

Triazolam tablets contain triazolam, a triazolobenzo-diazepine hypnotic agent. Triazolam is a white crystalline powder, soluble in alcohol and poorly soluble in water.

Triazolam tablets are indicated for the short-term treatment of insomnia (generally 7 to 10 days). Use for more than 2 to 3 weeks requires complete reevaluation of the patient (see WARNINGS).

Prescriptions for triazolam should be written for short-term use (7 to 10 days) and it should not be prescribed in quantities exceeding a 1-month supply.

TRIAZOLAM NEWS HIGHLIGHTS

Media Articles Related to Triazolam

Insomnia In Adolescence Linked To Depression And Substance Abuse During Adolescence And Young Adulthood
Source: Alcohol / Addiction / Illegal Drugs News From Medical News Today [2008.10.02]

Ten Tips to Avoid Insomnia and Get a Good Night's Sleep
Source: MedicineNet Sleep Aids And Stimulants Specialty [2008.06.05]

Persistent Insomnia Leads to Depression in Young Adults
Source: MedicineNet Sleep Aids And Stimulants Specialty [2008.04.03]

The Secret Causes of Insomnia: What Every Woman Should Know About Sleep Problems
Source: MedicineNet Restless Leg Syndrome Specialty [2008.02.20]

Insomnia Treatment: Sleep Aids and Stimulants
Source: MedicineNet Narcolepsy Specialty [2007.11.19]

more>>

Published Studies Related to Triazolam

Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women. [2008.04.01]

Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. [2006.11]

Dose effects of triazolam on brain activity during episodic memory encoding: a PET study. [2006.11]

Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam. [2006.04]

Effect of benzodiazepine hypnotic triazolam on relationship of blood pressure and Paco2 to cerebral blood flow during human non-rapid eye movement sleep. [2006.04]

more>>

Clinical Trials Related to Triazolam

A Study of the Acute Behavioral and Subjective Effects of TAK-375 [Completed]

Physiological, Behavioral and Subjective Effects of Drugs (GHB) [Recruiting]

Flumazenil Reversal of Oral Triazolam [Completed]

Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine [Completed]

more>>

Page last updated: 2008-10-02

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008